0001104659-21-151330.txt : 20211217
0001104659-21-151330.hdr.sgml : 20211217
20211217202602
ACCESSION NUMBER: 0001104659-21-151330
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211215
FILED AS OF DATE: 20211217
DATE AS OF CHANGE: 20211217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gilboa David Abraham
CENTRAL INDEX KEY: 0001883353
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40825
FILM NUMBER: 211503380
MAIL ADDRESS:
STREET 1: C/O WARBY PARKER INC.
STREET 2: 233 SPRING STREET, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10013
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Warby Parker Inc.
CENTRAL INDEX KEY: 0001504776
STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851]
IRS NUMBER: 800423634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 233 SPRING STREET
STREET 2: 6TH FLOOR EAST
CITY: NEW YORK
STATE: NY
ZIP: 10013
BUSINESS PHONE: (646) 847-7215
MAIL ADDRESS:
STREET 1: 233 SPRING STREET
STREET 2: 6TH FLOOR EAST
CITY: NEW YORK
STATE: NY
ZIP: 10013
FORMER COMPANY:
FORMER CONFORMED NAME: JAND, Inc.
DATE OF NAME CHANGE: 20101102
4
1
tm2135330-8_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-12-15
0
0001504776
Warby Parker Inc.
WRBY
0001883353
Gilboa David Abraham
C/O WARBY PARKER INC.,
233 SPRING STREET, 6TH FLOOR EAST
NEW YORK
NY
10013
1
1
0
0
Co-Chief Executive Officer
Class A Common Stock
2021-12-15
4
C
0
250000
0
A
250000
D
Class A Common Stock
2021-12-15
4
S
0
225564
43.3247
D
24436
D
Class A Common Stock
2021-12-15
4
S
0
24436
43.9553
D
0
D
Class A Common Stock
2021-12-16
4
C
0
1732
0
A
1732
D
Class A Common Stock
2021-12-16
4
S
0
1732
44.59
D
0
D
Class A Common Stock
2021-12-17
4
C
0
115000
0
A
115000
D
Class A Common Stock
2021-12-17
4
S
0
115000
44.923
D
0
D
Stock Option (Right to Buy)
0.72
2021-12-15
4
M
0
427000
0
D
Class B Common Stock
427000
228490
D
Class B Common Stock
2021-12-15
4
M
0
427000
0
A
Class A Common Stock
427000
6703796
D
Class B Common Stock
2021-12-15
4
C
0
250000
0
D
Class A Common Stock
250000
6453796
D
Restricted Stock Units
2021-12-16
4
M
0
1732
0
D
Class B Common Stock
1732
939020
D
Class B Common Stock
2021-12-16
4
M
0
1732
0
A
Class A Common Stock
1732
6455528
D
Class B Common Stock
2021-12-16
4
C
0
1732
0
D
Class A Common Stock
1732
6453796
D
Stock Option (Right to Buy)
0.72
2021-12-17
4
M
0
228490
0
D
Class B Common Stock
228490
0
D
Class B Common Stock
2021-12-17
4
M
0
228490
0
A
Class A Common Stock
228490
6682286
D
Class B Common Stock
2021-12-17
4
C
0
115000
0
D
Class A Common Stock
115000
6567286
D
Class B Common Stock
Class A Common Stock
0
2131770
I
By David A. Gilboa 2012 Family Trust
The price reported in Column 4 is a weighted average price. These shares were sold to cover taxes due on option exercises reported in Table II of this Form 4 in multiple transactions at prices ranging from $42.76 to $43.72. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold to cover taxes due on option exercises reported in Table II of this Form 4 in multiple transactions at prices ranging from $43.775 to $44.1017. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Sale of shares to cover taxes due on restricted stock units that vested on October 1, 2021 and November 1, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold to cover taxes due on option exercises reported in Table II of this Form 4 in multiple transactions at prices ranging from $44.72 to $45.13. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The Stock option was granted on July 27, 2012, is fully vested, and will expire on July 26, 2022.
The Class B Common Stock is convertible at any time at the option of the holder into the Issuer's Class A Common Stock on a one-to-one basis. The Class B Common Stock will automatically convert intoshares of the Issuer's Class A Common Stock on a one-to-one basis upon the earlier of (i) transfer of Class B common stock to a person or entity that is not in the transferor's permitted ownership group, (ii) October 1, 2031, (iii) with respect to any Class B common stock held by any person or entity in Neil Blumenthal's permitted ownership group, (A) such time as Neil Blumenthal is removed or resigns from theboard of directors, or otherwise ceases to serve as a director, (B) such time as Neil Blumenthal ceases to be either an employee, officer or consultant of the Company or any of its subsidiaries, or (C) the date that is 12 months after the death or disability of Neil Blumenthal,
and (iv) with respect to any Class B common stock held by any person or entity in Dave Gilboa's permitted ownership group, (A) such time as Dave Gilboa is removed or resigns from the board of directors, orotherwise ceases to serve as a director, (B) such time as Dave Gilboa ceases to be either an employee, officer or consultant of the Company or any of its subsidiaries, or (C) the date that is 12 months after the death or disability of Dave Gilboa.
Each Restricted Stock Unit represents a contingent right to receive one share of the Company's Class A Common Stock.
This filing relates to the occurrence of a RSU vesting event.
The restricted stock units will vest in 60 monthly installments beginning on July 1, 2021, will expire on June 15, 2031.
/s/ Hyung Bak, Attorney-in-Fact
2021-12-17